Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects

Steven M. Haffner, Katherine R. Tuttle, David L. Rainwater

    Research output: Contribution to journalArticle

    98 Scopus citations

    Abstract

    Objective: Recently, lipoprotein(a) [Lp(a)] has been identified as a major risk factor for coronary heart disease. There are few data available on the influence of metabolic control on plasma Lp(a) concentrations in subjects with insulin-dependent diabetes mellitus (IDDM), a group at high risk for coronary heart disease. Research Design and Methods: We examined the effects of improved metabolic control on plasma lipid and lipoproteins and Lp(a) concentrations in 12 subjects before and after 21 days of tight metabolic control. Results: Glycosylated hemoglobin declined from 8.4 to 6.9% (P < 0.001), and Lp(a) declined from 29.7 to 27.1 mg/dl (P = 0.022). There were no significant differences in total, low-density lipoprotein, or high-density lipoprotein cholesterol, although the decline in triglyceride concentrations were borderline statistically significant. The distribution of apolipoprotein(a) isoforms in IDDM patients was not unusual, and the apolipoprotein(a) isoform phenotypes did not change with improved metabolic control. Lp(a) concentrations were also significantly higher than in a population-based control group of nondiabetic subjects from the San Antonio Heart Study. Conclusions: Although the number of subjects was small and the degree of improvement in metabolic control was modest, the results suggest that improved metabolic control may decrease the risk of coronary heart disease mediated by Lp(a) in IDDM.

    Original languageEnglish (US)
    Pages (from-to)302-307
    Number of pages6
    JournalDiabetes care
    Volume14
    Issue number4
    DOIs
    StatePublished - Apr 1991

      Fingerprint

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Advanced and Specialized Nursing

    Cite this